Blinded procedure for New York Heart Association (NYHA) Class II or III heart failure, or Canadian Cardiovascular Society (CCS) Class III or IV chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (IDE) study
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $4,466.84 | $6,918.31 | $11,748.98 | |
Aetna
| Professional | $5,888.44 | $11,748.98 | $12,302.69 | |
Cigna
| Facility | $4,677.35 | $4,677.35 | $4,677.35 | |
Horizon BCBS
| Facility | $35,481.34 | $56,234.13 | $89,125.09 | |
United
| Facility | $5,888.44 | $12,302.69 | $38,904.51 |